New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy
Cited by 13
Related Papers
Puerarin alleviates delayed-type hypersensitivity via cytokine inhibition by modulating Th1/Th2 balance
|Experimental and Therapeutic Medicine|2018|11